153 results
Page 4 of 8
424B5
q89t2z5 yrxsj
11 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
ggmew 4kaqculdekclau
11 Feb 21
Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares
12:00am
8-K
EX-1.1
pcqomz3wu0zmje2
5 Feb 21
Iterum Therapeutics plc Announces $10 Million Bought Deal
5:09pm
424B5
9i16kgq
5 Feb 21
Prospectus supplement for primary offering
5:07pm
424B5
54au2qrxkibze
3 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-3.1
otkwoeee10s
28 Jan 21
Iterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem
4:16pm
8-K
EX-1.1
qb8 hk2au7fqmxli0
27 Oct 20
Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering
5:29pm
8-K
EX-10.1
vbe803
27 Oct 20
Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering
5:29pm
424B4
rgguzg8y7
26 Oct 20
Prospectus supplement with pricing info
5:28pm